Vivienne Rebel

Dr. Vivienne Rebel

Greehey Children’s Cancer Research Institute (GCCRI), The University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, TX, USA

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2005 in Science
Verified
Journal Article
Closed access
PDF file
FWFiona L. Watson
Fiona L. Watson
RPRoland Püttmann-Holgado
Roland Püttmann-Holgado
FTFranziska Thomas
Franziska Thomas
DLDavid L. Lamar
David L. Lamar
MHMichael Hughes
Michael Hughes
DSDietmar Schmucker
Dietmar Schmucker
The extensive somatic diversification of immune receptors is a hallmark of higher vertebrates. However, whether molecular diversity contributes to immune protection in invertebrates is unknown. We present evidence that Drosophila immune-competent cells have the potential to express more than 18,000 isoforms of the immunoglobulin (Ig)-superfamily receptor Down syndrome cell adhesion molecule (Dscam). Secreted protein isoforms of Dscam were detected in the hemolymph, and hemocyte-specific loss of Dscam impaired the efficiency of phagocytic uptake of bacteria, possibly due to reduced bacterial binding. Importantly, the molecular diversity of Dscam transcripts generated through a mechanism of alternative splicing is highly conserved across major insect orders, suggesting an unsuspected molecular complexity of the innate immune system of insects.

1 August 2004 in Cell
Verified
Journal Article
Closed access
KKKatarzyna Kozar
Katarzyna Kozar
MCMaria A. Ciemerych
Maria A. Ciemerych
VRVivienne Rebel
Vivienne Rebel
HSHirokazu Shigematsu
Hirokazu Shigematsu
AZAgnieszka Zagozdzon
Agnieszka Zagozdzon
PSPiotr Sicinski
Piotr Sicinski

1 February 2000 in Genes & Development
Verified
Journal Article
Closed access
PDF file
AKAndrew L. Kung
Andrew L. Kung
VRVivienne Rebel
Vivienne Rebel
RBRoderick T. Bronson
Roderick T. Bronson
LCLian-Ee Ch'NG
Lian-Ee Ch'NG
CSColin A. Sieff
Colin A. Sieff
TYTso-Pang Yao
Tso-Pang Yao
Mice with monoallelic inactivation of the CBP gene develop highly penetrant, multilineage defects in hematopoietic differentiation and, with advancing age, an increased incidence of hematologic malignancies. The latter are characterized, at least in some cases, by loss of heterozygosity (LOH) at the CBP locus. No such pathology was observed in wild-type or p300 heterozygous null mice of the same age and genetic background. Thus, a full complement of CBP, but not p300, is required for normal hematopoietic differentiation. These results also provide the first experimental evidence for the hypothesis that CBP has tumor-suppressing activity.

22 January 2015 in Blood
Verified
Journal Article
Open access
PDF file
AMAllison Mayle
Allison Mayle
LYLiubin Yang
Liubin Yang
BRBenjamin Rodriguez
Benjamin Rodriguez
TZTing Zhou
Ting Zhou
ECEdmund Chang
Edmund Chang
MGMargaret A. Goodell
Margaret A. Goodell
Key Points: Dnmt3a ablation in HSCs predisposes mice to develop a spectrum of myeloid and lymphoid malignancies. Dnmt3a-KO-derived myeloid malignancies and T-cell acute lymphocytic leukemia/lymphoma show distinct methylation aberrations.

23 October 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
VRVivienne Rebel
Vivienne Rebel
AKAndrew L. Kung
Andrew L. Kung
ETElizabeth A. Tanner
Elizabeth A. Tanner
HYHong Yang
Hong Yang
RBRoderick T. Bronson
Roderick T. Bronson
DLDavid M. Livingston
David M. Livingston
Hematopoietic stem cells (HSC) are tightly regulated through, as yet, undefined mechanisms that balance self-renewal and differentiation. We have identified a role for the transcriptional coactivators CREB-binding protein (CBP) and p300 in such HSC fate decisions. A full dose of CBP, but not p300, is crucial for HSC self-renewal. Conversely, p300, but not CBP, is essential for proper hematopoietic differentiation. Furthermore, in chimeric mice, hematologic malignancies emerged from both CBP −/− and p300 −/− cell populations. Thus, CBP and p300 play essential but distinct roles in maintaining normal hematopoiesis, and, in mice, both are required for preventing hematologic tumorigenesis.

1 June 2016 in Cancer Cell
Verified
Journal Article
Closed access
LYLiubin Yang
Liubin Yang
BRBenjamin Rodriguez
Benjamin Rodriguez
AMAllison Mayle
Allison Mayle
HPHyun Jung Park
Hyun Jung Park
XLXueqiu Lin
Xueqiu Lin
MGMargaret A. Goodell
Margaret A. Goodell